Skip to main content

Table 4 Sensitivity to change: PPSM-Global by Study Treatment Arms at 2 Years

From: The psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptoms

   PPSM Questionnaire – PPSM-Global  
   Visit 2
(Baseline)
Visit 10
(2 Years)
Change:
Visit 2 to Visit 10
Effect Size
Treatment Arm N Mean
(SD)
Mean
(SD)
Mean
(SD)
 
0.5 mg dutasteride + 0.4 mg tamsulosin 158 25.55
(6.61)
17.76
(6.88)
-7.79
(7.21)
-1.17
0.5 mg dutasteride + placebo 190 25.40
(5.20)
20.32
(7.57)
-5.07
(8.08)
-0.97
0.4 mg tamsulosin + placebo 161 25.66
(6.09)
20.47
(7.55)
-5.19
(7.88)
-0.85
  1. Notes: Sample for separate visit scores includes everyone that has a PPSMQ Total Score (excl. pain) at both time points.
  2. Effect size: Mean change score (visit 2 to visit 10) divided by standard deviation of visit 2 score